Stay updated on Lixivaptan Safety Assessment in ADPKD Completion: Clinical Trial
Sign up to get notified when there's something new on the Lixivaptan Safety Assessment in ADPKD Completion: Clinical Trial page.

Latest updates to the Lixivaptan Safety Assessment in ADPKD Completion: Clinical Trial page
- Check4 days agoChange DetectedThe footer now identifies the site as revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check11 days agoChange DetectedA sitewide NIH notice announces the transition from “Artificial Intelligence” to “Super Intelligence” terminology and links to transition updates and FAQs.SummaryDifference0.7%

- Check18 days agoChange DetectedThe ClinicalTrials.gov site revision changed from v3.7.1 to v3.7.2; the study record content remains unchanged.SummaryDifference0.1%

- Check25 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check46 days agoChange DetectedNew revision entry added to the history, updating the version from v3.6.6 to v3.7.0. This reflects an updated page version without changing the underlying study data.SummaryDifference0.1%

- Check67 days agoChange DetectedA new Revision: v3.6.6 entry was added to the study history, and the previous Revision: v3.6.5 was removed. This represents a small maintenance update to the page's revision log.SummaryDifference0.1%

Stay in the know with updates to Lixivaptan Safety Assessment in ADPKD Completion: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lixivaptan Safety Assessment in ADPKD Completion: Clinical Trial page.